Ischemia–reperfusion rat model of acute pancreatitis: protein carbonyl as a putative early biomarker of pancreatic injury
Loading...
Date
Journal Title
Journal ISSN
Volume Title
Publisher
Clinical and Experimental Medicine
Abstract
Acute pancreatitis (AP) is an inflammatory
disorder that can affect adjacent and/or remote organs.
Some evidence indicates that the production of reactive
oxygen species is able to induce AP. Protein carbonyl (PC)
derivatives, which can also be generated through oxidative
cleavage mechanisms, have been implicated in several
diseases, but there is little or no information on this bio marker in AP. We investigated the association between
some inflammatory mediators and PC, with the severity of
ischemia–reperfusion AP. Wistar rats (n = 56) were ran domly assigned in the following groups : control; sham, 15-
or 180-min clamping of splenic artery, with 24 or 72 h of
follow-up. The relationships between serum level of PC
and thiobarbituric acid reactive species (TBARS) to mye loperoxidase (MPO) activity in tissue homogenates and to
cytokines in culture supernatants of pancreatic samples
were analyzed. MPO activity was related to the histology
scores and increased in all clamping groups. Tumor
necrosis factor-alpha (TNF-a), interleukin 1 beta (IL-1b),
and interleukin-6 were higher in the 180-min groups. Sig nificant correlations were found between MPO activity and
the concentrations of TNF-a and IL-1b. PC levels
increased in the 15-min to 24-h group. TBARS levels were
not altered substantially. MPO activity and TNF-a and IL 1b concentrations in pancreatic tissue are correlated with
AP severity. Serum levels of PC appear to begin to rise
early in the course of the ischemia–reperfusion AP and are
no longer detected at later stages in the absence of severe
pancreatitis. These data suggest that PC can be an efficient
tool for the diagnosis of early stages of AP.
Description
p. 311–320.: il. color.
Citation
SCHANAIDER, Alberto et al. Ischemia–reperfusion rat model of acute pancreatitis: protein carbonyl as a putative early biomarker of pancreatic injury. Clinical and Experimental Medicine, v. 15, p. 311–320, 2015.